主页

Vanesa Gregorc

申请预约

专科:

肿瘤科肺癌及胸部肿瘤头颈癌黑色素瘤及非黑色素瘤皮肤癌

职业:

肿瘤科医生

医疗机构:

临床肿瘤科 @ 圣拉斐尔科学研究医院

语言:

申请预约

个人简介

Vanesa Gregorc医生是意大利米兰圣拉斐尔科学研究医院肿瘤科和分子肿瘤学研究部的高级顾问。Gregorc医生是圣拉斐尔生命健康大学医学院国际项目的肿瘤学课程教授。

Gregorc教授是抗癌联盟肺部工作组：意大利癌症研究所卓越网络的秘书长；还加入了以下工作组：黑色素瘤、免疫学和基因组学。

Gregorc医生同时管理着25项临床试验和3项研究项目。Gregorc医生参与了50多项临床试验，还开展了研究者发起的试验。其中的Prose研究已在ASCO 2013肺癌主要会议上公布，并已纳入NCCI指南。Gregorc医生还与意大利卫生部和一些制药公司有长期合作关系。

您需要预约吗？

联系我们，我们将为您妥善安排。

申请预约

出版物

最新出版物

Aspetti psicologici del tumore del polmone. Capitolo del libro “Psiconcologia"

P. Catanzaro, V. Gregorc.

Mesotelioma, Eziopatogenesi, presentazione clinica e percorso diagnostico-terapeutico

Medicina e Diritto 3/2009, Sessione Focus. pg 14-23, Maggioli Editore

Ghio D, Gregorc V.

Relevance Of P53, Bcl-2 And Rb Expression On Resistance To Cisplatin-Based Chemotherapy In Advanced Non Small Cell Lung Cancer (NSCLC)

Lung Cancer (2003) 41-48

V. Gregorc, V. Ludovini, L. Pistola, S. Darwish, I. Floriani, G. Bellezza, A. Sidoni, A. Cavaliere, M. Scheibel, V. De Angelis, E. Bucciarelli, M. Tonato.

Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer

Cancer. 2007 Aug 15;110(4):845-53.

Gregorc V, Spreafico A, Floriani I, Colombo B, Ludovini V, Pistola L, Bellezza G, Vigano MG, Villa E, Corti A.

Germline polymorphisms in EGFR and survival in patients with lung cancer receiving gefitinib

Clin Pharmacol Ther. 2008 Mar;83(3):477-84.

Gregorc V, Hidalgo M, Spreafico A, Cusatis G, Ludovini V, Ingersoll RG, Marsh S, Steinberg SM, Viganò MG, Ghio D, Villa E, Sparreboom A, Baker SD.

Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours

Br J Cancer. 2009 Jul 21;101(2):21924.

Gregorc V, Santoro A, Bennicelli E, Punt CJ, Citterio G, Timmer-Bonte JN, Caligaris Cappio F, Lambiase A, Bordignon C, van Herpen CM.

Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial.

Lancet Oncol. 2014 Jun;15(7):713-21.

Gregorc V, Novello S, Lazzari C, Barni S, Aieta M, Mencoboni M, Grossi F, Pas TD, de Marinis F, Bearz A, Floriani I, Torri V, Bulotta A, Cattaneo A, Grigorieva J, Tsypin M, Roder J, Doglioni C, Levra MG, Petrelli F, Foti S, Viganò M, Bachi A, Roder H.

Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer Failing First-Line PlatinumBased Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor

The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial J Thorac Oncol. J Thorac Oncol. 2017 Apr;12(4):752-762

Peters S, Stahel RA, Dafni U, Ponce Aix S, Massutí B, Gautschi O, Coate L, López Martín A, van Heemst R, Berghmans T, Meldgaard P, Cobo Dols M, Garde Noguera J, Curioni-Fontecedro A, Rauch D, Mark MT, Cuffe S, Biesma B, van Henten AM, Juan Vidal Ó, Palmero Sanchez R, Villa Guzmán JC, Collado Martin R, Peralta S, Insa A, Summers Y, Láng I, Horgan A, Ciardiello F, de Hosson S, Pieterman R, Groen HJ,

Combined exosomal RNA and circulating tumor DNA for epidermal growth factor mutation detection in non-small cell lung cancer

J Thorac Dis. 2018 Nov;10(Suppl 33):S4023-S4027. doi: 10.21037/jtd.2018.10.17.

Petrelli F, Lazzari C, Ardito R, Borgonovo K, Bulotta A, Conti B, Cabiddu M, Capitanio JF, Brighenti M, Ghilardi M, Gianni L, Barni S, Gregorc V. Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studies. PLoS One. 2018 Jul 27;13(7):e0201425. doi: 10.1371/journal.pone.0201425. eCollection 2018. Lazzari C, Gregorc V, Cangi MG, Giovannetti E, Bulotta

PD-1 Inhibitors-Related Neurological Toxicities in Patients with Non-Small-Cell Lung Cancer: A Literature Review. Cancers (Basel)

2019 Mar 1;11(3). pii: E296. doi: 10.3390/cancers11030296.

Mirabile A, Brioschi E, Ducceschi M, Piva S, Lazzari C, Bulotta A, Viganò MG, Petrella G, Gianni L, Gregorc V.

您需要预约吗？

联系我们，我们将为您妥善安排。

申请预约